These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30496765)

  • 1. Passive immunotherapy with specific IgG fraction against autolysin: Analogous protectivity in the MRSA infection with antibiotic therapy.
    Kalali Y; Haghighat S; Mahdavi M
    Immunol Lett; 2019 Aug; 212():125-131. PubMed ID: 30496765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive immunization against methicillin resistant Staphylococcus aureus recombinant PBP2a in sepsis model of mice: Comparable results with antibiotic therapy.
    Naghshbandi RZ; Haghighat S; Mahdavi M
    Int Immunopharmacol; 2018 Mar; 56():186-192. PubMed ID: 29414649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel recombinant vaccine candidate comprising PBP2a and autolysin against Methicillin Resistant Staphylococcus aureus confers protection in the experimental mice.
    Haghighat S; Siadat SD; Sorkhabadi SMR; Sepahi AA; Mahdavi M
    Mol Immunol; 2017 Nov; 91():1-7. PubMed ID: 28858628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, expression and purification of autolysin from methicillin-resistant Staphylococcus aureus: potency and challenge study in Balb/c mice.
    Haghighat S; Siadat SD; Sorkhabadi SM; Sepahi AA; Mahdavi M
    Mol Immunol; 2017 Feb; 82():10-18. PubMed ID: 28006655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monophosphoryl lipid A as a co-adjuvant in methicillin-resistant Staphylococcus aureus vaccine development: improvement of immune responses in a mouse model of infection.
    Mirshekar M; Haghighat S; Mousavi Z; Abdolghaffari AH; Yazdi MH
    Immunol Res; 2024 Jun; 72(3):490-502. PubMed ID: 38383811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant PBP2a of methicillin-resistant S. aureus formulation in Alum and Montanide ISA266 adjuvants induced cellular and humoral immune responses with protection in Balb/C mice.
    Mortazavi SS; Haghighat S; Mahdavi M
    Microb Pathog; 2020 Mar; 140():103945. PubMed ID: 31874228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant PBP2a as a vaccine candidate against methicillin-resistant Staphylococcus aureus: Immunogenicity and protectivity.
    Haghighat S; Siadat SD; Rezayat Sorkhabadi SM; Akhavan Sepahi A; Sadat SM; Yazdi MH; Mahdavi M
    Microb Pathog; 2017 Jul; 108():32-39. PubMed ID: 28457901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting surface protein SasX by active and passive vaccination to reduce Staphylococcus aureus colonization and infection.
    Liu Q; Du X; Hong X; Li T; Zheng B; He L; Wang Y; Otto M; Li M
    Infect Immun; 2015 May; 83(5):2168-74. PubMed ID: 25776748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic selenium nanoparticles as co-adjuvant improved immune responses against methicillin-resistant Staphylococcus aureus.
    Ranjbariyan A; Haghighat S; Yazdi MH; Arbabi Bidgoli S
    World J Microbiol Biotechnol; 2022 Nov; 39(1):16. PubMed ID: 36401129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human monoclonal antibody targeting the conserved staphylococcal antigen IsaA protects mice against Staphylococcus aureus bacteremia.
    van den Berg S; Bonarius HP; van Kessel KP; Elsinga GS; Kooi N; Westra H; Bosma T; van der Kooi-Pol MM; Koedijk DG; Groen H; van Dijl JM; Buist G; Bakker-Woudenberg IA
    Int J Med Microbiol; 2015 Jan; 305(1):55-64. PubMed ID: 25466204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal immunization with wall teichoic acid (WTA) elicits and augments an anti-WTA IgG response that protects mice from methicillin-resistant Staphylococcus aureus infection independent of mannose-binding lectin status.
    Takahashi K; Kurokawa K; Moyo P; Jung DJ; An JH; Chigweshe L; Paul E; Lee BL
    PLoS One; 2013; 8(8):e69739. PubMed ID: 23936347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of Staphylococcus aureus from
    Harro JM; Achermann Y; Freiberg JA; Allison DL; Brao KJ; Marinos DP; Sanjari S; Leid JG; Shirtliff ME
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31712267
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
    Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
    mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential binding of human and murine IgGs to catalytic and cell wall binding domains of Staphylococcus aureus peptidoglycan hydrolases.
    Wang M; van den Berg S; Mora Hernández Y; Visser AH; Vera Murguia E; Koedijk DGAM; Bellink C; Bruggen H; Bakker-Woudenberg IAJM; van Dijl JM; Buist G
    Sci Rep; 2021 Jul; 11(1):13865. PubMed ID: 34226629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucomannan as a polysaccharide adjuvant improved immune responses against Staphylococcus aureus: Potency and efficacy studies.
    Dehnavi M; Haghighat S; Yazdi MH; Mahdavi M
    Microb Pathog; 2023 Mar; 176():106007. PubMed ID: 36709850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis.
    Nishitani K; Beck CA; Rosenberg AF; Kates SL; Schwarz EM; Daiss JL
    Clin Orthop Relat Res; 2015 Sep; 473(9):2735-49. PubMed ID: 26013151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering of Long-Circulating Peptidoglycan Hydrolases Enables Efficient Treatment of Systemic Staphylococcus aureus Infection.
    Sobieraj AM; Huemer M; Zinsli LV; Meile S; Keller AP; Röhrig C; Eichenseher F; Shen Y; Zinkernagel AS; Loessner MJ; Schmelcher M
    mBio; 2020 Sep; 11(5):. PubMed ID: 32963004
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus.
    Aguilar JL; Varshney AK; Pechuan X; Dutta K; Nosanchuk JD; Fries BC
    Virulence; 2017 Aug; 8(6):741-750. PubMed ID: 27715466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of Staphylococcus aureus biofilm infection using vaccination and antibiotic treatment.
    Brady RA; O'May GA; Leid JG; Prior ML; Costerton JW; Shirtliff ME
    Infect Immun; 2011 Apr; 79(4):1797-803. PubMed ID: 21220484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective opsonic activity of antibodies against fibronectin-binding proteins (FnBPs) of Staphylococcus aureus.
    Rozalska B; Wadström T
    Scand J Immunol; 1993 May; 37(5):575-80. PubMed ID: 8484103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.